This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Vanda Pharmaceuticals Inc (VNDA)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 64.76M 88.77M 87.92M 42.56M
Receivables 2.03M 1.17M 1.62M 511.00K
Inventories 0.00 57.00K 0.00 0.00
Other Current Assets 128.00K 0.00 0.00 0.00
Total Current Assets 135.61M 125.97M 153.50M 200.57M
Property, Plant & Equipment, Gross 3.45M 3.17M 4.04M 3.60M
Accumulated Depreciation & Depletion 1.25M 818.00K 3.07M 2.66M
Property, Plant & Equipment, Net 2.20M 2.35M 964.00K 937.00K
Intangibles 5.04M 6.53M 8.03M 9.52M
Other Non-Current Assets 500.00K 600.00K 20.13M 430.00K
Total Non-Current Assets 7.74M 9.48M 29.12M 12.53M
Liabilities & Shareholder Equity
Total Assets 143.35M 135.45M 182.62M 213.10M
Accounts Payable 661.00K 287.00K 996.00K 648.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 221.00K 3.90M 0.00 2.27M
Total Current Liabilities 32.85M 32.26M 31.62M 31.03M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 2.89M 3.00M 461.00K 490.00K
Other Non-Current Liabilities 63.49M 90.28M 117.06M 143.85M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 66.37M 93.28M 117.52M 144.34M
Total Liabilities 99.22M 125.54M 149.14M 175.37M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 44.12M 9.90M 33.47M 37.73M
Common Par 33.00K 28.00K 28.00K 28.00K
Additional Paid In Capital 355.43M 300.97M 296.87M 291.34M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -311.36M -291.11M -263.44M -253.64M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 21.00K 10.00K 21.00K 2.00K
Total Capitalization 44.12M 9.90M 33.47M 37.73M
Total Equity 44.12M 9.90M 33.47M 37.73M
Total Liabilities & Stock Equity 143.35M 135.45M 182.62M 213.10M
Total Common Shares Outstanding 33.34M 28.24M 28.12M 28.04M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 30.35M 28.23M 28.11M 27.92M
Diluted Weighted Shares Outstanding 30.35M 28.23M 28.11M 28.53M
Number of Employees 53 40 38 28
Number of Part-Time Employees 0 0 0 0

VNDA Vanda Pharmaceuticals Inc

Analysts Ratings for VNDA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

VNDA Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs